Kurzporträt
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
C. Trenary
CEO | Chief Executive Officer | 66 | 07.07.21 |
Lawrence Kenyon
DFI | Director of Finance/CFO | 58 | 15.09.15 |
Surendra Sharma
CTO | Chief Tech/Sci/R&D Officer | - | 19.01.23 |
Terry Dagnon
COO | Chief Operating Officer | 62 | 01.11.18 |
Alicia Tozier
SAM | Sales & Marketing | - | 02.03.22 |
Joel Prieve
PRN | Corporate Officer/Principal | - | 08.02.22 |
Jeff Evanson
PRN | Corporate Officer/Principal | 55 | 01.11.18 |
Jennifer Kissner
PRN | Corporate Officer/Principal | - | 26.04.19 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Randy Thurman
CHM | Chairman | 74 | 13.04.18 |
Kurt Hilzinger
BRD | Director/Board Member | 63 | 11.12.15 |
C. Trenary
CEO | Chief Executive Officer | 66 | 07.07.21 |
Lawrence Kenyon
DFI | Director of Finance/CFO | 58 | 15.09.15 |
Yazan Haddadin
BRD | Director/Board Member | 48 | 31.10.17 |
Julian Gangolli
BRD | Director/Board Member | 66 | 20.04.20 |
Gerd Auffarth
BRD | Director/Board Member | 59 | 20.04.20 |
Julia Haller
BRD | Director/Board Member | 69 | 11.08.22 |
Director/Board Member | 39 | 11.09.17 | |
Andong Huang
BRD | Director/Board Member | 27 | 19.06.20 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 22 298 542 | 13 636 212 ( 61,15 %) | 0 | 61,15 % |
Unternehmenskontakt
Outlook Therapeutics, Inc.
485 Route 1 South Building F, Suite 320
08852, Iselin
+609 619 3990
http://www.outlooktherapeutics.comSektor
% 1. Jan. | Kap. | |
---|---|---|
+25,69 % | 47,9 Mrd. | |
+46,90 % | 41,42 Mrd. | |
-3,46 % | 40,7 Mrd. | |
-6,20 % | 28,92 Mrd. | |
+9,17 % | 25,55 Mrd. | |
-20,42 % | 19,27 Mrd. | |
+0,17 % | 12,15 Mrd. | |
+28,07 % | 12,14 Mrd. | |
-1,24 % | 11,99 Mrd. |